The hydrogen deuterium exchange (HDX) mass spectrometry combined with molecular dynamics (MD) simulations was employed to investigate conformational dynamics and ligand binding within the M49 family (dipeptidyl peptidase III family). Six dipeptidyl peptidase III (DPP III) orthologues, human, yeast, three bacterial and one plant (moss) were studied. According to the results, all orthologues seem to be quite compact wherein DPP III from the thermophile Caldithrix abyssi seems to be the most compact.
Introduction
Dipeptidyl peptidase III (DPP III) enzymes belong to the M49 metallopeptidase family. 1 To cleave dipeptides from the Ntermini of various peptides consisting of three to ten amino acids, they need the zinc cation positioned within the active site.
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Human dipeptidyl peptidase III (hDPP III, UniProt entry: Q9NY33) can also be found labelled as enkephalinase B because it degrades neuropeptide enkephalin which takes part in pain regulation. 3, 4 Overexpression of hDPP III is observed in several pathophysiological conditions but its exact function is not entirely understood.
5-7 Besides human DPP III, a number of the other M49 family orthologues, from eukaryotic (mammals, 1 plants, 8 insects, 9 yeast
10
) and prokaryotic (bacteria 11, 12 ) organisms, have been identied. Their presence in different cells where they participate in the nal steps of a protein catabolism indicates their importance for life. [13] [14] [15] [16] [17] Until now several 3D structures of human DPP III (hDPP III) have been determined, both ligand free and in complexes with natural peptides (PDB_codes 3FVY and 5EGY and 3T6B, 3T6J, 5E33, 5E3A, 5E2Q, 5EHH and 5E3C, respectively). 18, 19 Additionally, the crystal structures for yeast and two bacterial orthologues (Bacteroides thetaiotaomicron and Caldithrix abyssi) were determined as well (PDB_codes: 3CSK, 5NA7 and 6EOM, respectively). Although the structures of all these DPP III orthologues have a characteristic M49 family fold organized in two domains, with an upper domain having a conserved motif of amino acids responsible for the zinc ion binding and catalytic function, separation, and orientation of domains signicantly differ. An exception is a similarity between the unliganded yeast (yDPP III) and human DPP III (PDB_codes: 3CSK and 3FVY, respectively) 10, 18 structures with RMSD of 2.17 A (calculated for 676 amino acids residues backbone) though their sequence identity is only about 35%. In these structures, domains are separated with a wide cle so we call them open. In all crystal structures of hDPP III, except 3FVY, the domains are close to each other, and entrance to the active site is closed (PDB_codes: 5EGY, and 3T6B, 3T6J, 5E3A, 5E2Q, 5EHH and 5E3C). 19 Computational studies have shown that the closed form is energetically more favorable for the catalytic reaction 20 but it is too compact to allow the substrate molecule to enter the binding site. The molecular simulations showed that hDPP III protein in solution predominantly resides in semi-closed conformation. 21, 22 The crystal structures of the hDPP III in complexes with substrates and inhibitors revealed similar binding of peptides (substrates and inhibitors) with different amino acid sequences and length and suggested that the large domain motion induced by their binding is also conserved. 19 This nding is in accord with a low specicity of DPP III enzymes towards the amino acid composition of peptide substrates. 11, 23, 24 In the crystal structure of the hDPP IIItynorphin complex (PDB codes 3T6B and 3T6J), the ligand has an extended conformation and it forms several backbone hydrogen bonds with the ve-stranded b-core of the lower domain. The Nterminus is also stabilized by the lower domain residues while the second peptide bond carbonyl is hydrogen bonded to His568 from the upper domain ensuring proper positioning of the cleaving peptide bond with respect to the catalytic zinc ion. However, differences in enzyme activity 25 and inhibition 26, 27 observed for other DPP III orthologues indicate that the tynorphin binding mode, as well as overall enzyme exibility, might be different in these complexes. In this study for the rst time hydrogen deuterium exchange reaction (HDX) followed by mass spectrometry 28, 29 was applied to investigate the conformational dynamics conservation within the M49 (DPP III) enzyme family. HDX is effective method for localizing and determining protein stability and dynamics. 30 Combined with molecular docking and dynamics simulations, it can be used for computer-aided drug design. 31 Only a few peptidases have been studied using HDX approach. Most recently, dynamics and ligand-induced conformational changes in human prolyl oligopeptidase were analyzed by HDX. 32 Our HDX experiments were performed for six orthologues: human (hDPP III), yeast (yDPP III), Bacteroides thetaiotaomicron (BtDPP III), Porphyromonas gingivalis (PgDPP III), Physcomitrella patens (PpDPP III) and Caldithrix abyssi (CaDPP III). The hexapeptide zinc binding motif (HEXXGH) was established as a "hallmark" of this family, 2 required for the hydrolytic activity. However, in some new members of the M49 family, conserved hexapeptide motif is reduced to the pentapeptide HEXXH. Among the enzymes considered in this study, the DPP III orthologues from thermophile C. abyssi and moss P. patens, contain the pentapeptide motif. HDX exibility map was obtained for each unliganded protein allowing localization of the conformational dynamics within the macromolecular sequence and the experimental value was mapped onto the protein 3D structure. Besides conformational dynamics of the ligand free peptidases, tynorphin binding into the interdomain cle and its inuence on the domain motion was investigated as well. By comparing the results of the HDX experiments with molecular modelling data we determined details of the enzyme-ligand interactions.
Experimental methods

Heterologous expression and purication
All DPPs III were expressed in E. coli as recombinant proteins with a C-terminal His 6 -tag and puried using affinity chromatography and size exclusion chromatography. Detailed expression protocols were described elsewhere. 8, 12, 25, 26, 33 Protein purity was conrmed by SDS-PAGE according to Laemmli. 34 Protein concentrations were determined by the Bradford method. 35 
Determination of kinetic parameters
The K m values for hydrolysis of uorogenic substrate Arg 2 -2NA were determined at pH 7.4 (20 mM Tris-HCl buffer) and at 25 C, from the initial reaction rates as previously described.
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Under the conditions used, the K m values were 6.0 mM, 12 mM and 0.8 mM for human, yeast, and B. thetaiotaomicron DPP III, and 0.3 mM, 15.9 mM and 23.8 mM for Porphyromonas gingivalis, Caldithrix abyssi and Physcomitrella patens enzyme, respectively. Enzyme inhibition studies with tynorphin were performed using the Arg 2 -2NA as a substrate, according to Baršun et al.
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The inhibition constant, K i , was calculated according to the equation:
where v 0 and v i are the initial hydrolysis rates of Arg 2 -2NA (given in concentration s) catalyzed by DPP III in the absence and presence of inhibitor concentration (i), and K m is the Michaelis constant.
H/D exchange experiment
In the rst step of the HDX analysis, optimization of digestion conditions and establishing a list of peptic peptides for all DPP III orthologues was carried out. With non-deuterated sample, a 5 mL aliquot of protein stock (between 35-50 mM in 20 mM Tris, pH 7.4) was diluted 10 times by adding 45 mL of 20 mM Tris, pH 7.4 (H 2 O reaction buffer). Next, the sample was acidied by mixing with 10 mL of 2 M glycine buffer, pH 2.5 (H 2 O stop buffer). The sample was subjected to online pepsin digestion using a 2.1 mm Â 30 mm immobilized pepsin resin column (Porozyme, ABI, Foster City, CA) with 200 mL min À1 ow of 0.07% formic acid in water as a mobile phase. Digested peptides were passed directly to the 2.1 mm Â 5 mm C18 trapping column (Acquity BEH C18 VanGuard precolumn, 1.7 mm resin, Waters, Milford, MA). Trapped peptides were eluted onto a reverse phase column (Acquity UPLC BEH C18 column, 1.0 Â 100 mm, 1.7 mm resin, Waters, Milford, MA) using a 6% to 40% gradient of acetonitrile in 0.1% formic acid (ow 40 mL min À1 )
supplied by a nanoACQUITY Binary Solvent Manager. The total time of a single run was 13.5 minutes. All uidics, valves, and columns were maintained at 0.5 C using the HDX Manager (Waters, Milford, MA) except the pepsin digestion column, which was kept at 20 C inside the temperature-controlled digestion column compartment of the HDX manager. The C18 column outlet was coupled directly to the ion source of a SYN-APT G2 HDMS mass spectrometer (Waters, Milford, MA) working in ion mobility mode. Lock mass was activated and carried out using leucine-enkephalin (Sigma 39, 40 In both cases models were built from two parts. The 3D structure of the DPP III domains were determined using the experimentally determined structures of BtDPP III (PDB_code: 5NA7) and CaDPP III (PDB_code: 6EOM), respectively. The sequence similarity between BtDPP III and the DPP III domain of PgDPP III is 51%, while between CaDPP III and the DPP III domain of PpDPP III it is 42%. In order to identify a suitable templates for the ARM and NUDIX domains a PSI-BLAST 41 search was done. Following the multiple sequence alignment by Clustal Omega (https://www.ebi.ac.uk/Tools/msa/ clustalo/) the 3D structures of PgDPP III and PpDPP III were determined using the program Modeller wherein for the ARM domain of PgDPP III (660-886 aa residues) the 3D structure with PDB_code 3ZBO was used as a template, and for the NUDIX domain of PpDPP III (aa 1-160 residues) the 3D structure with PDB_code 2FKB.
Molecular dynamics (MD) simulations
MD simulations were accomplished for all ligand free DPP III orthologues as well as for their complexes with tynorphin, except for the PpDPP III. In the case of human, yeast, B. thetaiotaomicron and C. abyssi DPP III, the crystallographically determined structures were used as initial structures while for the P. gingivalis and P. patens DPP III the initial structures were derived using homology modelling.
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The protein parametrisation was performed within the ff14SB 42 force eld using leap, a basic preparation program for Amber simulations available within the AMBER16 package (http:// ambermd.org). 43, 44 For the zinc ion, Zn 2+ , parameters derived in previous work were used. 24 All Arg and Lys residues in the structure were positively charged (+1e) while Glu and Asp residues were negatively charged (À1e), as expected at the physiological (experimental) conditions. The protonation of histidines was checked according to their ability to form hydrogen bonds with neighboring amino acid residues or to coordinate the metal ion.
The proteins and protein-substrate complexes were placed into a truncated octahedron box lled with TIP3P water molecules, 45 and Na + ions 46 were added in order to neutralize the systems.
Before running productive molecular dynamics simulations, the protein geometry was optimized in three cycles (every 1500 steps) and the system was equilibrated. In the rst cycle of optimization, water molecules were relaxed, while the rest of the system was harmonically restrained with a force constant of 32 kcal mol À1ÅÀ1 . In the second and third cycle, the same force constant (32 kcal mol À1ÅÀ1 ) was applied to the zinc ion, while the protein backbone was restrained with force constants of 12 and 2 kcal mol À1 A À1 , respectively. The energy minimization procedure, consisting of 470 steps of steepest descent followed by conjugate gradient optimization for the remaining steps, was the same in all cycles. During the rst period of equilibration (200 ps of gentle heating from 0 to 300 K with a time step of 1 fs), the NVT ensemble was used, while all of the following simulations were performed at constant temperature and pressure (300 K and 1 atm, 2 fs time step, the NpT ensemble). During the equilibration, the zinc ion and/or its ligands were weakly restrained. The temperature was held constant using Langevin dynamics 47 with a collision frequency of 1 ps À1 . The pressure was regulated by a Berendsen barostat. 48 Bonds involving hydrogen atoms were constrained using the SHAKE 49,50 algorithm. The ligand free proteins for which the crystal structure was available were equilibrated for 1 ns and in the case of the initial structure derived by comparative modelling 50 ns of equilibration was performed. For each orthologue at least 150 ns of productive MD simulations was accomplished.
Docking
In the case of hDPP III-tynorphin complex the crystal structure of the complex (PDB_code: 3T6B) was used as initial, while in the case of the other orthologues complexes were derived using the hDPP III-tynorphin complex as a template and the most appropriate orthologue structure generated during the simulations of the ligand free protein. As the most appropriate structure we assumed semi-closed enzyme form from the trajectory region with stable RMSD. Namely our earlier exhaustive investigations of the DPP III conformational search 21 have indicated that the semi-closed enzyme are the most populated in water and therefore probably the most reactive state for substrate recognition. Thus obtained complexes were energy minimized and equilibrated using the same procedure as described above for the ligand free enzyme. The equilibrated complexes were simulated for at least 100 ns.
Data analysis
The hydrogen bond analyses were performed with the CPPTRAJ module 51 of the Amber16 program package.
Results and discussion
Conformational dynamics of the unliganded human DPP III
Online pepsin digestion of the human DPP III protein showed excellent proteolytic efficiency due to the high enzyme/protein ratio and produced enough fragments to achieve 93.7% of the sequence coverage during 1.5 min digestion time (see Fig. S1A †) . In human DPP III four highly exible regions with fast H/D exchange were identied ( Fig. 1 Table S1 . † 22 For all peptides, we measured binomial exchange prole (EX2 exchange regime) indicating that amide hydrogens visit exchange competent state many times before one hydrogen is replaced with deuterium.
In other words for all hDPP III peptides, local unfolding/ folding is faster than it is their exchange reaction rate. Broadening of the peptide isotopic envelope due to deuterium incorporation follows a binomial distribution. Agreement between the measured deuterium uptake and the uptake determined from the amide hydrogen bond analysis during MD simulations (Fig. S2 †) was obtained with a correlation coefficient of 0.766. Calculation of the theoretical values is carried out according to the similar procedure already published. 52 Apart from the limitations of MD simulation, i.e. the conformations sampled during 150 ns present only a part of the protein conformational space, the correlation between the experimental and theoretical data depends on the quality of the HDX prediction model and approximations that are taken into account as well.
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Structure exibility conservation within DPP III family Measurement of the localized hydrogen deuterium exchange data at different time intervals (from 10 seconds to 4 hours) allowed us to discern conformational dynamics at narrow regions of the enzyme structure and to identify the fast, medium and slow H/D exchanging peptides.
Peptides with deuterium uptake larger than 30% of their available amide hydrogens aer the shortest (10 seconds) exchange time period indicate region permanently exposed to water or region that oen becomes exposed to solvent under conformational changes of the protein. On the other hand, peptides having less than 20% of their available amide hydrogens exchanged with deuterium aer the longest (4 hours) exchange time period correspond to the protected, hydrophobically shielded protein regions with amide hydrogens involved in the internal hydrogen bond network. The ratio of fast and slow exchanging peptides can be considered a measure of enzyme conformational plasticity. For human DPP III the fast exchanging peptides cover just 12% of the amino acid sequence. The comparable level of H/D exchange was determined for all unliganded DPP III orthologues wherein the largest share of the fast exchanging peptides was found in yeast DPP III (Table 2 ). More detailed insight into the local conformational behavior of the unliganded DPP III enzymes was provided by analyzing relative fractional uptake values for the peptic peptides. The values measured for human and yeast orthologues are shown in Fig. 2 . It can be noticed that patterns of the peptides with high H/D exchange determined for these two enzymes are similar. The peptides with the highest exchange ratio are part of the protein regions that visit the exchange-competent state many times during the labelling periods. Region I includes the amino acid residues 263-443 and 270-453 in the hDPP III and yDPP III, respectively and comprises several secondary structure elements, equivalent in hDPP III and yDPP III wherein the largest (ve strands) b-sheet denes the bottom of the active site cavity. This region also includes the hinge region and several helices. In hDPP III these are helices 17, 18 and 19 in the hairpin, and helices 14, 15, 16 in the lower domain. Region II covers the unstructured loop in the upper domain between amino acid residues His450 and Tyr506. Region III covers motifs located in the upper domain; the beta hairpin (E), helices 31, 32 and 33 and the hinge region between Arg669 and Val673; a second strand of the beta sheet (A), the beta hairpin (F) and helix 34 (see Fig. S1B †) . Peptides with minimum exchange indicate the highly protected protein regions with the amide hydrogens involved in stable internal hydrogen bonds. Such regions are helices 2, 3, 6, 35 and partially helices 12 and 14 in the lower domain of hDPP III and helices 23, 25 and 27 comprising the upper domain core. The substantial diversity in the enzymes amino acid composition (Table S2 and Fig. S3 †) gives an explanation for the variability of the HDX proles determined for different members of the M49 enzyme family. As can be seen by comparing the exibility proles of different M49 orthologues (Fig. S4 †) the highest similarity between the deuterium uptake determined in different orthologues is in the region denoted as Region I in hDPP III. This common HDX pattern is related to the DPP III inter-domain dynamics. By comparing the structure of the unliganded hDPP III with the hDPP III structure in its complex with tynorphin Bezerra et al. 18 found that the long range conformational change of the protein structure could be described as domain rotation around the 'peptide hinge' 409 LGNVLAVAYATQ 420 . For all DPP III orthologues the HDX study revealed EX2 exchange regime except for the yeast DPP III peptide 407 
VRLKIGFKNVSLGNIL
422 which exhibited mixed EX1/EX2 kinetics (Fig. 3) . This peptide comprises the hinge residues 418 LGNIL 422 corresponding to residues 409 LGNVL 413 of hDPP III. Bimodal broadening of the isotope envelope (Fig. 3 ) observed in this case indicates that interdomain motion which exposes this peptide to interact with deuterated solvent is slower than chemical exchange rate of the exposed amide hydrogen's so that several of them exchange at once. Such behavior is opposite to that represented with binomial broadening (Fig. 3) were inter-domain motion is fast enough so that hDPP III peptide 399 RQTEGFKNVSLGNVL 413 visits exchange competent conformation many times before one amide hydrogen is exchanged. Replacement of valine at position 412 with more bulky isoleucine has not resulted with the EX1/EX2 HDX kinetics in the human V412I mutant. Namely, the peptide 399 RQTEGFKNVSLGNIL 413 bearing isoleucine instead of valine still exhibited binomial exchange prole (EX2 exchange regime, Fig. 3 ) although overall exchange was higher than it was for wild type hDPP III (Fig. 3) . Conformational space sampled during MD simulation is close to fully folded protein form 56 covering fast local structural uctuations which correspond to peptides that follow EX2 HDX kinetics and have binomial isotopic envelope broadening. Yeast DPPIII 407 VRLKIGFKNVSLGNIL 422 is the only peptide in this study that was exhibiting mixed EX1/EX2 exchange kinetics indicating existence of population with different conformational states where one of them is populated as a result of larger inter-domain motion occurring on relatively slower timescale (EX1) which was not identied in MD simulation. The conformation of the peptide (VRLKIGFKNVSLGNIL) itself has not changed signicantly during the simulations, but its accessibility to solvent did. Namely, we traced two different forms of its surrounding; one in which the peptide's backbone is mostly solvated with SASA of the peptide nitrogen atoms (Val407N-Leu422N) being 6.1 A 2 and the other in which it is more protected with SASA of N407-N422 of 1.6 A 2 (Fig. S5 †) . According to this result, we could assume that these two forms of yDPPP III are (more or less) equally populated in the solution during the HDX experiment.
Tynorphin inhibition study, impact on the DPP III activity
Opioid pentapeptide tynorphin (VVYPW) has been shown to be a potent inhibitor of DPP III hydrolytic activity. 57 Earlier investigations suggested that the ligand binding into the interdomain cle inuences the large domain motion and induces striking compression of human and bacterial DPP III orthologues. 18, 19, 21, 58 We assumed that comparative (differential) H/D exchange study on ligand free enzymes and their complexes with tynorphin would enable us to reveal the degree of conservation of the ligand binding site and inuence of the ligand, tynorphin, binding on the enzyme exibility.
The kinetic measurements of the enzyme inactivation by tynorphin revealed the different degree of inactivation in studied orthologues. As shown in Table 2 , all six studied DPP III enzymes were inhibited by tynorphin. However, inhibitory potency differed signicantly. Human DPP III was the most inhibited while four enzymes yDPP III, BtDPP III, PgDPP III and PpDPP III have had inhibition constant values 10-30 times higher, and the K i value for CaDPP III was 500-fold increased, compared to hDPP III.
Inuence of the tynorphin binding to DPP III exibility
Comparison of the deuterium uptake by the matching peptides in unliganded hDPP III and its complex with tynorphin enabled us to localize changes in HDX rate upon tynorphin binding and to investigate the inuence of ligand binding on the protein conformation and dynamics (Fig. 4A ). In the crystal structure of the hDPP III complex tynorphin is bound in the form of a bstrand to the ve-stranded b-core of the lower domain in an antiparallel fashion. 18 In (Fig. 4A) . These results are in agreement with the rearrangement of the protein intermolecular hydrogen bonds in these regions and their increased solvent accessibility noticed during the inter-domain conformation changes induced by ligand binding (Table S3 †) . During MD simulations of the human DPP III-tynorphin complex the ligand remained bound in an antiparallel fashion to a ve-stranded b-core from the lower protein domain. The representative orientation of the ligand is shown in Fig. 5 . Plots of the intermolecular hydrogen bonds lengths changes during MD simulations, as well as overlay of the starting and nal conformation are given in Fig. S7 . † It is interesting to notice that most of the peptides showing an increase of the deuterium uptake upon ligand binding, like p2, p34 and p55/p56, are situated on the "back", convex, side of the protein for which MD simulations had already reported 21 the increase in residue based solvent accessible surface area during protein closure. Agreement with experiment was also obtained for the peptides p13, p34 and p55/p56 for which we have determined smaller mean number of hydrogen bonds per residue in the liganded enzyme structure than in the unliganded one (Table S3 †) . Consequently, the same four peptides from the lower domain (p29, p38, p39 and p40) and p62 peptide from the upper hDPP III domain interact with tynorphin and establish larger mean number of hydrogen bonds per residue in 422 from yeast DPP III shows complex profiles due to the mixed EX1/EX2 exchange regime. In the corresponding deuterium uptake plot (right) pink dots represent the slow exchanging conformer and yellow dots the fast exchanging conformer.
the complex structure than in the ligand-free structure obtained by the MD simulations (Table S3 †) .
Although tynorphin binding did not induce the deuterium uptake increase in any region of yDPP III, its binding induced the deuterium uptake decrease in the upper part of the lower domain ve-stranded b-core (Fig. 4B) as it was determined in the case of hDPP III. We assumed that the tynorphin binding modes in human and yeast DPP III are similar and built the yDPP III-tynorphin complex accordingly. During 100 ns of MD simulations the tynorphin remained bound in the form of a bstrand into the enzyme active site, close to the lower domain bcore. The representative orientation of the ligand is shown in Fig. 4 Graphical representation of the deuterium uptake differences found for peptic peptides of human and yeast DPP III by comparing two states, unliganded enzyme and its tynorphin complex. Presented are statistically significant values calculated as the difference in the area under deuterium uptake curves of two protein states (unliganded enzyme and its tynorphin complex) which is normalized to a maximal possible deuterium uptake curve area for that specific peptide. All differences are shown in Fig. S6 . † Light blue bars denote positive differences, meaning that area under uptake curve was larger for unliganded enzyme than for its complex with tynorphin. Positive difference colored black is for slow exchanging conformer and dark blue for fast exchanging conformer. Pink bars denote negative differences indicating that deuterium uptake in the region of protein structure covered by the corresponding peptide was higher upon tynorphin binding. Such color-coded values for the labelled peptides are mapped onto a corresponding enzyme-tynorphin structure. (A) Ribbon representation of the hDPP III structure bound to the tynorphin inhibitor from a front (left) and back (right) view of the active site cleft. (B) Ribbon representation of the yDPP III structure bound to the tynorphin inhibitor from a front (left) and back (right) view of the active site cleft. In both structures, tynorphin was presented by colored sphere atoms (orange-C, white-H, red-O and blue-N). For the peptides' identification (sequences), see Table S1 . † Fig. 6 , and the RMSD plot of the tynorphin backbone, as well as the overlay of three conformations generated during MD simulations are given in Fig. S8 . † This is in agreement with the HDX results which revealed deuterium uptake decrease in the peptides from the predicted tynorphin binding site: 290 exchange kinetics and deuterium incorporation decrease in tynorphin complex. Decrease of less than 1% was measured for fast exchanging conformation indicating very weak protection from tynorphin. For slow exchanging conformation deuterium incorporation decrease is more than 22% indicating much stronger protection of the bound tynorphin ( Fig. 3 and 4B) . Beside the ligand binding region, the reduced deuterium uptake was also observed in several other peptides from both lower domain: 160 
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171 (p17), 172 LGFPSQGYTSA (Fig. S8 †) , indicating that these peptides are either approaching the bound substrate (p52) or protein residues from the other domain (p17 and p20) in the yDPP III-tynorphin complex. Differential HDX experiment with the human V412I mutant was carried out to check the importance of the amino acid composition within the hinge region for the conformation dynamics of the complex. By changing valine at position 412 in hDPP III to isoleucine the same amino acid composition in the hinge region of human ( to each other by conformational change during the transition from open into the closed conformation. The position of these two peptides suggests that in the closed conformation the two domains are placed relative to each other like it was observed for yDPP III complex indicating a signicant impact of the amino acid composition of the hinge region to the mode of closure and the inter-domain position. The H/D exchange curve observed for the mutant p40 peptide (Fig. 3) indicates faster deuterium exchange in the V412I mutant than in the wild-type hDPP III. This nding together with the absence of deuterium uptake increase in mutated enzyme suggests that the protein closure upon ligand binding is less pronounced in the V412I mutant than in the wild-type hDPP III. Differential analysis of the HDX data obtained for two bacterial DPP III homologs, from Bacteroides thetaiotaomicron and Porphyromonas gingivalis, revealed only a weak inuence of the tynorphin binding on the HDX kinetics ( Fig. 7 and 8 ). Such ndings are in agreement with the recently published crystal structure of the ligand free BtDPP III, which is signicantly more compact than human DPP III, 59 and MD simulations results of the BtDPP III which showed that the amplitude of the interdomain separation in hDPP III is signicantly larger than in BtDPP III. 58 In the case of BtDPP III the slight decrease in the deuterium uptake was observed for three peptides, 382 behavior has been previously reported for the BtDPP III-Arg 2 -2NA complex. 58 However, this conformational transition has not been traced during MD simulations of the ligand-free enzyme (Fig. S10 †) .
PgDPP III is signicantly larger (886 amino acid residues) than human, yeast, and B. thetaiotaomicron DPP III. It has all the evolutionarily conserved regions of the DPP III family but, differently from the other characterized DPP III orthologues, it possesses a C-terminal extension containing an armadillo (ARM) type of fold similar to that of the AlkD family of bacterial DNA glycosylases.
However, complementation assays in a DNA-repair-decient Escherichia coli strain indicated the absence of alkylation repair function of this enzyme. On the other hand, its peptidase activity is comparable to that of BtDPP III. 33 Weak changes of the HDX proles upon the enzyme complexation with tynorphin were detected in the DPP III part of the protein region represented by peptides p18, p37, p39, and p45, ( 12 In the case of PgDPP III this resulted in concurrent movements of both the lower DPP III domain and ARM fragment in the direction of the upper DPP III domain as it was discussed in our recent publication. 33 This could serve as an explanation for the measured HDX decrease in the regions distant from the tynorphin binding site.
The plant DPP III from moss Physcomitrella patens (PpDPP III), differently from the other DPP III orthologues, contains the so-called NUDIX motif on the N-terminal part of the sequence, a characteristic of Nudix hydrolases (Fig. 9) . 8 Changes in HDX kinetics were detected only in part of the sequence covering DPP III domains, but not in the NUDIX domain ( Fig. 9 and S6E †). All peptides with the reduced deuterium uptake upon complexation are located within the active site cle indicating that tynorphin interacts with larger part of the beta core from the lower domain and so signicantly reduces conformational dynamics of the active site cle region.
Peptides with reduced deuterium uptake, p50, p53, p57 581 , respectively) contain amino acid residues from the ligand binding subsites and according to the molecular modelling results they take part in ligand stabilization (Fig. S12 †) .
Comparing the HDX data obtained for unliganded DPP III from Caldithrix abyssi (CaDPP III) and its complex with tynorphin revealed signicant changes of the HDX kinetics in the upper domain induced by tynorphin binding. Even though the b-sheet in the lower domain was again identied as a potential substrate binding place (moderately small decrease of the deuterium uptake was observed in one peptide covering part of Fig. 7 Graphical representation of the deuterium uptake differences found by comparing two states of the BtDPP III (unliganded enzyme and its complex with tynorphin). Ribbon representation of the BtDPP III structure (PDB accession number 5NA7) bound to the tynorphin inhibitor from a front (left) and side (right) view of the active site cleft is shown. For the peptides identification (sequences), see Table S1 . † Fig. 8 Graphical representation of the deuterium uptake differences found by comparing two states of the PgDPP III (unliganded enzyme and its complex with tynorphin). Ribbon representation of the modelled PgDPP III structure bound to the tynorphin inhibitor from a front (left) and side (right) view of the active site cleft is shown. For the peptides identification (sequences), see Table S1 . † Table S5 † for the hydrogen bond population in the relevant peptides). However, like in the mesophylic orthologues, tynorphin binds in the form of a b-strand into the CaDPP III active site, close to the lower domain b-core (Fig. 11) . Both X-ray diffraction and MD simulations showed that the structure of the ligand free CaDPP III is much more compact than the ligand free structures of the other DPP III orthologues, which might be the reason for the signicantly higher K i value determined for tynorphin. 12, 18, 19, 59 Conclusions In this work, we investigated conservation of the conformational exibility within the DPP III enzyme family using HDX-MS experiments combined with MD simulations. Altogether, 6 DPP III orthologues have been studied: human, yeast, three bacterial and moss.
Inspection of the H/D exchange in conserved protein regions revealed that the region containing the hexapeptide (or pentapeptide in the case of CaDPP III and PpDPP III) signature motif is, in general, among the most protected, i.e. the most rigid, regions within the considered orthologues, with exception of CaDPP III. The relative protection is highest in the human orthologue, in agreement with its high activity. In addition, results of H/D exchange experiment agree with the results of MD simulations which showed that in solution the semi-closed human DPP III form is the most populated one.
The similarities in the human and yeast DPP III exibility proles are closely correlated with the similarity of their 3D structures (RMSD of about 2 A).
Besides the exibility conservation, we also studied the possible differences in the ligand, pentapeptide tynorphin, Fig. 9 Graphical representation of the deuterium uptake differences found by comparing two states of the PpDPP III (unliganded enzyme and its complex with tynorphin). Ribbon representation of the modelled PpDPP III structure bound to the tynorphin inhibitor from a front (left) and side (right) view of the active site cleft is shown. For the peptides identification (sequences), see Table S1 . † Fig. 10 Graphical representation of the deuterium uptake differences found by comparing two states of the CaDPP III (unliganded enzyme and its complex with tynorphin). Ribbon representation of the CaDPP III structure bound to the tynorphin inhibitor from a front (left) and back (right) view of the active site cleft is shown. For the peptides identification (sequences), see Table S1 . † accommodation into the enzyme and its inuence on the protein conformation and local exibility.
Despite differences in orthologues' structure and exibility, we found that in all cases tynorphin binds to the upper part of the lower domain b-sheet.
It seems that the more structured enzymes (i.e. enzymes with small share portion of unstructured regions like loops), such as human and C. abyssi DPP III, are more sensitive to ligand binding than those whose structure is more disordered, e.g. BtDPP III and PgDPP III. The tynorphin binding mode previously determined in human DPP III by X-ray diffraction is, according to the differential H/D exchange study and MD simulations, preserved in complexes with different DPP III orthologues.
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